Improving prognostication in patients with hepatocellular carcinoma undergoing loco-regional therapy using pre- and post-locoregional therapy scores

被引:0
作者
Thandassery, Ragesh B. [1 ]
Lavender, Charles A. [1 ]
Perisetti, Abhilash [1 ]
Beheshti, Michael [2 ]
机构
[1] Cent Arkansas Vet Healthcare Syst, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA
[2] Cent Arkansas Vet Healthcare Syst, Dept Diagnost Imaging, Little Rock, AR USA
关键词
Hepatocellular carcinoma; Locoregional therapy; BCLC staging; Prognostication; FATTY LIVER-DISEASE; TRANSARTERIAL CHEMOEMBOLIZATION; SURGICAL RESECTION; UNITED-STATES; NIACE SCORE; EPIDEMIOLOGY; RETREATMENT; SURGERY; HCC;
D O I
10.1007/s00261-023-04111-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundMany scoring systems have been proposed for predicting survival in patients with hepatocellular carcinoma (HCC) undergoing locoregional therapy (LRT). We aimed to study the role of the NIACE score, hepatoma arterial embolization prognostic score (HAP), and ABCR score in predicting transplant-free survival (TFS) in these patients.MethodsIn this retrospective multicenter study of a United States Veteran cohort who underwent LRT, NIACE, HAP, and ABCR scores were calculated, and their predictive accuracy for TFS within different modified BCLC (mod-BCLC) stages was analyzed.Results180 subjects underwent LRT between January-2012 and March-2019 were followed till January-2022, mean age 65.6 +/- 6.3 years, model for end-stage liver disease -sodium (MELD-Na) score (at first LRT) 14.1 +/- 6.7. A total of 43.9%, 35%, and 21.1% of patients had mod-BCLC A, B, and C stage disease, respectively. A total of 76.7% underwent transarterial embolization (TAE), 6.1% underwent ablation, and 17.2% underwent transarterial radioembolization (TARE) as the first intervention and were followed for a median of 576.5 patient-years. The NIACE score, HAP score, and ABCR scores differentiated patients within mod-BCLC stages A and B into groups with significant differences in TFS. In the stratified analysis of those undergoing only TAE, all three scores identified subgroups with significantly different TFS.ConclusionIn patients with HCC undergoing LRT, the mod-BCLC stages have subgroups with variable overall TFS. The NIACE score, HAP score, and ABCR score identified differential prognoses is within mod-BCLC stages and characterized subgroups with different TFS following LRT (TAE). Integration of these scoring systems into treatment decisions would help to improve prognostication within respective mod-BCLC groups, which may help with more customized treatment allocation.
引用
收藏
页码:631 / 641
页数:11
相关论文
共 24 条
[1]   NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization [J].
Adhoute, Xavier ;
Penaranda, Guillaume ;
Raoul, Jean Luc ;
Bollon, Emilie ;
Pol, Bernard ;
Letreut, Yves P. ;
Perrier, Herve ;
Bayle, Olivier ;
Monnet, Olivier ;
Beaurain, Patrick ;
Muller, Cyril ;
Hardwigsen, Jean ;
Lefolgoc, Gaelle ;
Castellani, Paul ;
Bronowicki, Jean P. ;
Bourliere, Marc .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (06) :706-715
[2]   Hepatocellular carcinoma scoring and staging systems. Do we need new tools? [J].
Adhoute, Xavier ;
Penaranda, Guillaume ;
Raoul, Jean-Luc ;
Bourliere, Marc .
JOURNAL OF HEPATOLOGY, 2016, 64 (06) :1449-1450
[3]   Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C: results from a French multicenter study [J].
Adhoute, Xavier ;
Penaranda, Guillaume ;
Raoul, Jean L. ;
Blanc, Jean F. ;
Edeline, Julien ;
Conroy, Guillaume ;
Perrier, Herve ;
Pol, Bernard ;
Bayle, Olivier ;
Monnet, Olivier ;
Beaurain, Patrick ;
Muller, Cyril ;
Castellani, Paul ;
Bronowicki, Jean-Pierre ;
Bourliere, Marc .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (04) :433-440
[4]   Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process [J].
Adhoute, Xavier ;
Penaranda, Guillaume ;
Naude, Sebastien ;
Raoul, Jean Luc ;
Perrier, Herve ;
Bayle, Olivier ;
Monnet, Olivier ;
Beaurain, Patrick ;
Bazin, Christophe ;
Pol, Bernard ;
Le Folgoc, Gaelle ;
Castellani, Paul ;
Bronowicki, Jean Pierre ;
Bourliere, Marc .
JOURNAL OF HEPATOLOGY, 2015, 62 (04) :855-862
[5]  
[Anonymous], 2023, STUDY TACE COMBINED
[6]   Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease [J].
Bertot, Luis Calzadilla ;
Adams, Leon A. .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (02) :179-187
[7]   Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization [J].
Ciria, R. ;
Lopez-Cillero, P. ;
Gallardo, A. -B. ;
Cabrera, J. ;
Pleguezuelo, M. ;
Ayllon, M. -D. ;
Luque, A. ;
Zurera, L. ;
Espejo, J. -J. ;
Rodriguez-Peralvarez, M. ;
Montero, J. -L. ;
de la Mata, M. ;
Briceno, J. .
EJSO, 2015, 41 (09) :1153-1161
[8]   Comparison of Surgical Resection and Transarterial Chemoembolization for Hepatocellular Carcinoma beyond the Milan Criteria: A Propensity Score Analysis [J].
Hsu, Chia-Yang ;
Hsia, Cheng-Yuan ;
Huang, Yi-Hsiang ;
Su, Chien-Wei ;
Lin, Han-Chieh ;
Pai, Jih-Tung ;
Loong, Che-Chuan ;
Chiou, Yi-You ;
Lee, Rheun-Chuan ;
Lee, Fa-Yauh ;
Huo, Teh-Ia ;
Lee, Shou-Dong .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (03) :842-849
[9]   How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma [J].
Hucke, Florian ;
Pinter, Matthias ;
Graziadei, Ivo ;
Bota, Simona ;
Vogel, Wolfgang ;
Mueller, Christian ;
Heinzl, Harald ;
Waneck, Fredrik ;
Trauner, Michael ;
Peck-Radosavljevic, Markus ;
Sieghart, Wolfgang .
JOURNAL OF HEPATOLOGY, 2014, 61 (06) :1287-1296
[10]   Cancer statistics, 2007 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Murray, Taylor ;
Xu, Jiaquan ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) :43-66